CVS Health’s iShares 1-5 Year Investment Grade Corporate Bond ETF IGSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$86.6M Buy
1,690,000
+800,000
+90% +$41.6M 20.16% 1
2026
Q2
$46.6M Buy
890,000
+595,600
+202% +$31.2M 20.72% 1
2026
Q1
$15.5M Buy
294,400
+200,000
+212% +$10.6M 7.29% 4
2025
Q4
$4.99M Buy
+94,400
New +$5M 3.69% 5

Other funds holding IGSB

CVS Health's IGSB Position: Q3 2026 in Review

CVS Health increased its iShares 1-5 Year Investment Grade Corporate Bond ETF (IGSB) stake by 90% in Q3 2026, buying an estimated $41.6M and bringing the position to 1,690,000 shares worth $86.6M. The position accounts for 20.16% of the portfolio, ranked #1.

CVS Health first reported a position in IGSB in Q4 2025 and has held it in 4 quarters since. 1,028 funds tracked by Wall St. Rank hold IGSB as of Q3 2026.

  • CVS Health held 1,690,000 shares of iShares 1-5 Year Investment Grade Corporate Bond ETF worth $86.6M as of Q3 2026.
  • CVS Health bought 800,000 iShares 1-5 Year Investment Grade Corporate Bond ETF shares in Q3 2026, an estimated $41.6M.
  • iShares 1-5 Year Investment Grade Corporate Bond ETF made up 20.16% of CVS Health's portfolio in Q3 2026, its #1 holding.
  • CVS Health first reported a position in iShares 1-5 Year Investment Grade Corporate Bond ETF in Q4 2025 and has held it in 4 quarters since.
  • 1,028 funds tracked by Wall St. Rank held iShares 1-5 Year Investment Grade Corporate Bond ETF as of Q3 2026.

Based on CVS Health's 13F filing for Q3 2026, filed 5 Nov 2026.